CRVS
Corvus Pharmaceuticals, Inc.Closed9.41−0.64 −6.37%USD
NasdaqGM · as of Oct 13, 16:00 ET · 15m delayAfter hours 9.41 0.00%
Open
9.99
Prev close
10.05
Day range
9.3210.03
52-week range
6.3926.95
Volume
1.69M1.75×
Mkt cap
791.58M
P/E ttm
—
Fwd P/E
-8.81
EPS ttm
-0.6200
Div yield
0.00%
Earnings
Aug 6, 2026
From 52w high
−65.08%
CRVS market-implied price distribution
CRVS Price at Expiry
10 OTM quotes · ATM IV 91.4%
Days to expiry
38
Fri, Nov 20, 2026
P(finish above spot)
51%
spot 9.41
Expected price
9.65
forward 9.72
68% range
6–12
−31.2% / +31.8%
Shaded band: the middle 68% of outcomes. Where the blue curve sits above the dashed one, options price that move as likelier than a plain bell curve would.
Target Price
Percentiles
| Chance below | Price | vs spot |
|---|---|---|
| 5% | 5.11 | −45.6% |
| 16% | 6.48 | −31.2% |
| 25% | 7.52 | −20.1% |
| 50% (median) | 9.45 | +0.4% |
| 75% | 11.38 | +20.9% |
| 84% | 12.40 | +31.8% |
| 95% | 15.09 | +60.4% |
Move Odds
| Up 5% or more (9.88) | 44% |
|---|---|
| Up 10% or more (10.35) | 37% |
| Down 5% or more (8.94) | 43% |
| Down 10% or more (8.47) | 36% |
Options price a 10%+ drop at 36%, 1.0× the 37% a bell curve with the same volatility gives.
Risk-neutral odds from option prices, the bot's lgf odds method: out-of-the-money mids → implied vols → a smoothed smile in total variance → density = erT·∂²C/∂K² (Breeden–Litzenberger). Risk-neutral odds include the market's risk premium, so they lean bearish compared with real-world odds. Not investment advice.